SOT (Short Oligonucleotide Therapy)

Treatment for Lyme, Lyme co-infections and other viruses

SOT is a treatment that was originally created in Europe over 20 years ago by the name of anti-sense oligonucleotide therapy (AOT). There have been decades of research from both European and American based companies and universities on SOT/AOT. RGCC labs has improved this technology and renamed it SOT because the treatment is now based on the patient’s unique genetic molecules. In the United States, Hepatitis C is now “cured” with this exact same FDA approved technology. If we can turn off Hepatitis C with one dose of an anti-sense therapy then we can turn off the same replication cycles of Lyme Disease, Lyme co-infections, viruses and even cancer cells, thus making SOT a very attractive therapy. 

How does SOT work?

After a lab draw, the patients’ blood is sent to RGCC labs in Greece. RGCC will then identify the main genetic sequence (gene epitope) of your target genes and then the gene sequences are cross referenced to an international database of genetics to confirm they have the proper sequences. RGCC created this unique fingerprinting technology, which ensures success of the treatment. It creates a 98% specificity to our target genes, such as the Lyme spirochetes or viruses, and it does not interfere with any other human cells. Once the replication genes are identified, the lab creates the anti-copy of the replication of the translocation genes (sense strand). RGCC splices apart this sense strand and makes a complimentary copy of the DNA sequences that creates replication. This in turn creates an anti-sense therapy. When the genetic sequence of a particular gene is known to be a causative agent of particular disease, it is possible to synthesize a strand of nucleic acid (DNA, RNA or a chemical analogue) that will bind to the messenger RNA (mRNA) produced by that gene and effectively turning that gene “off”. This is called gene silencing therapy or apoptosis inducing therapy. 

Once the lab creates the complimentary copy of the replication sequences, they surround this copy with a synthetic mRNA so that it can penetrate within the cell wall of our target. Once this mRNA sequence is created, it is replicated 500 million to 1 billion times producing a large number of your unique SOT molecules. These molecules are delivered to our office where you receive your single dose IV treatment. 

After being infused by the SOT molecules, the nucleotides are at work 24 hours a day, seven days a week for up to 4-6 months, constantly inhibiting the replication cycle of your target viruses or spirochetes. This makes SOT an effective approach to our target focus which can be Lyme, cancer or any other virus that differs from the genetics of our original gene structure. 

Are there any dangers with SOT?

There have never been any anaphylactic reactions from the SOT procedure. Most patients who experience any side effects feel them about 24-48 hrs. after the infusion. Symptoms are similar to what would be felt during a detox, such as headache, body aches, fatigue, etc. and have been known to last for up to 1 week. Most patients seem to have the most detox from EBV and Lyme. Patients are encouraged to retest 4-6 months after the SOT infusion to see if additional doses are needed. The risks of SOT infusion are primarily related to the sudden death of the cells.  

Click the images below to listen to 3 stories of people who used SOT in their healing journey.

The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.